A Zorzi, K Deyle,
C Heinis - Current opinion in chemical biology, 2017 - Elsevier
Highlights•On average, one cyclic peptide drug is approved every year.•New strategies
based on rational design and in vitro evolution deliver peptides to new targets.•Many of the …